AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano Research Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

Rapid and sensitive detection of Epstein-Barr virus antibodies in nasopharyngeal carcinoma by chemiluminescence strips based on iron-porphyrin single atom nanozyme

Daji Wang1,§( ), Jie Wang1,3,§, Dan Liu2,§, Jiuyang He4, Meiying Wang5, Haibing Huang3, Guohui Nie3, Hui Ding3( ), Xiyun Yan1,4( )
Nanozyme Synthesis Center, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Shenzhen Institute of Translational Medicine, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China
CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
Department of Rheumatology and Immunology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen 518055, China

§ Daji Wang, Jie Wang, and Dan Liu contributed equally to this work.

Show Author Information

Graphical Abstract

The iron-porphyrin based metal organic framework (MOF-FeP) is rationally synthesized to mimic the active site of natural peroxidase. The peroxidase-like activity of MOF-FeP enables it to catalyze the chemiluminescence of luminol. By integrating MOF-FeP into traditional strips, a rapid and highly-sensitive evaluation tool is created for simultaneously detecting three Epstein-Barr virus (EBV)-IgAs, greatly improving the accuracy of EBV-associated nasopharyngeal carcinoma screening.

Abstract

The correlation between Epstein-Barr virus (EBV) infection and nasopharyngeal carcinoma (NPC) risk has been extensively researched. The continual monitoring of EBV-IgAs provides a promising approach of NPC screening in its early stage. In this study, we successfully synthesized a single-atom nanozyme (SANzyme) through the application of iron-porphyrin based metal organic framework (MOF-FeP). The MOF-FeP possesses precisely-defined electronic and geometric structures that accurately mimic highly-evolved catalytic site of natural peroxidase. The peroxidase-like activity of MOF-FeP enables it to catalyze the chemiluminescence of luminol substrate. By integrating MOF-FeP into a traditional strip, we created a rapid and highly-sensitive evaluation tool for detecting EBV-IgAs. Importantly, the MOF-FeP strip enables the simultaneous detection of three EBV-IgAs, greatly improving the accuracy of EBV-associated NPC screening. The sensitivities of the MOF-FeP strip (75.56%–93.30%) surpass those of current enzyme-linked immunosorbent assay (ELISA) methods (64.44%–82.22%). This test takes only 16 min to perform as opposed to the customary 1–2 h required for standard ELISA. Additionally, the MOF-FeP strip is suitable for whole blood samples, thereby significantly simplifying the sample preparation and detection process. In conclusion, the MOF-FeP strip combines the simplicity of traditional strip with the high catalytic activity of SANzyme. Our innovative MOF-FeP strip offers a new point-of-care strategy for EBV-IgAs detection, which is expected to markedly facilitate early screening for EBV-associated diseases.

Keywords

iron-porphyrinchemiluminescence stripsantibody detectionsingle-atom nanozyme (SANzyme)Epstein-Barr virus (EBV)nasopharyngeal carcinoma (NPC)

Electronic Supplementary Material

Download File(s)
12274_2023_5915_MOESM1_ESM.pdf (1.1 MB)

References

[1]
Lee, H. M.; Okuda, K. S.; González, F. E.; Patel, V. Current perspectives on nasopharyngeal carcinoma. In Human Cell Transformation. Rhim, J. S.; Dritschilo, A.; Kremer, R. , Eds.; Springer: Cham, 2019; pp 11–34.
Crossref
[2]

Wei, K. R.; Zheng, R. S.; Zhang, S. W.; Liang, Z. H.; Li, Z. M.; Chen, W. Q. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin. J. Cancer 2017, 36, 90.
Crossref Google Scholar
[3]

Zheng, S. H.; Wang, Y. T.; Liu, S. R.; Huang, Z. L.; Wang, G. N.; Lin, J. T.; Ding, S. R.; Chen, C.; Xia, Y. F. Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study. Cancer Cell Int. 2022, 22, 36.
Crossref Google Scholar
[4]

Mahdavifar, N.; Ghoncheh, M.; Mohammadian-Hafshejani, A.; Khosravi, B.; Salehiniya, H. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res. Perspect. 2016, 7, 360–372.
Crossref Google Scholar
[5]

Lu, T. Z.; Guo, Q. J.; Lin, K. Y.; Chen, H. L.; Chen, Y. X.; Xu, Y. J.; Lin, C.; Su, Y.; Chen, Y.; Chen, M. Y. et al. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma. Cancer Sci. 2020, 111, 1711–1723.
Crossref Google Scholar
[6]

Soldan, S. S.; Lieberman, P. M. Epstein-Barr virus and multiple sclerosis. Nat. Rev. Microbiol. 2023, 21, 51–64.
Crossref Google Scholar
[7]

Feng, G. F.; Xu, Y. F.; Ma, N.; Midorikawa, K.; Oikawa, S.; Kobayashi, H.; Nakamura, S.; Ishinaga, H.; Zhang, Z.; Huang, G. W. et al. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma. BMC Cancer 2021, 21, 929.
Crossref Google Scholar
[8]

Li, Y. Q.; Khin, N. S.; Chua, M. L. K. The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma. Cancer Biol. Med. 2018, 15, 1–5.
Crossref Google Scholar
[9]

Ji, M. F.; Wang, D. K.; Yu, Y. L.; Guo, Y. Q.; Liang, J. S.; Cheng, W. M.; Zong, Y. S.; Chan, K. H.; Ng, S. P.; Wei, W. I. et al. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br. J. Cancer 2007, 96, 623–630.
Crossref Google Scholar
[10]

Cao, S. M.; Liu, Z. W.; Jia, W. H.; Huang, Q. H.; Liu, Q.; Guo, X.; Huang, T. B.; Ye, W. M.; Hong, M. H. Fluctuations of Epstein-Barr virus serological antibodies and risk for nasopharyngeal carcinoma: A prospective screening study with a 20-year follow-up. PLoS One 2011, 6, e19100.
Crossref Google Scholar
[11]

Chien, Y. C.; Chen, J. Y.; Liu, M. Y.; Yang, H. I.; Hsu, M. M.; Chen, C. J.; Yang, C. S. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N. Engl. J. Med. 2001, 345, 1877–1882.
Crossref Google Scholar
[12]

Li, T. D.; Guo, X. Y.; Ji, M. F.; Li, F. G.; Wang, H.; Cheng, W. M.; Chen, H. L.; Ng, M.; Ge, S. X.; Yuan, Y. et al. Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma. Cancer Med. 2018, 7, 1458–1467.
Crossref Google Scholar
[13]

Gao, L. Z.; Zhuang, J.; Nie, L.; Zhang, J. B.; Zhang, Y.; Gu, N.; Wang, T. H.; Feng, J.; Yang, D. L.; Perrett, S. et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat. Nanotechnol. 2007, 2, 577–583.
Crossref Google Scholar
[14]

Lin, L. H.; Li, H.; Gu, H. F.; Sun, Z. Y.; Huang, J.; Qian, Z. N.; Li, H.; Liu, J. Z.; Xi, H. Y.; Wu, P. F. et al. Asymmetrically coordinated single-atom iron nanozymes with Fe-N1C2 structure: A peroxidase mimetic for melatonin detection. Nano Res. 2023, 16, 4751–4757.
Crossref Google Scholar
[15]

Chen, M.; Zhou, H.; Liu, X. K.; Yuan, T. W.; Wang, W. Y.; Zhao, C.; Zhao, Y. F.; Zhou, F. Y.; Wang, X.; Xue, Z. G. et al. Single iron site nanozyme for ultrasensitive glucose detection. Small 2020, 16, 2002343.
Crossref Google Scholar
[16]

Shi, C.; Li, Y.; Gu, N. Iron-based nanozymes in disease diagnosis and treatment. ChemBioChem 2020, 21, 2722–2732.
Crossref Google Scholar
[17]

Duan, D. M.; Fan, K. L.; Zhang, D. X.; Tan, S. G.; Liang, M. F.; Liu, Y.; Zhang, J. L.; Zhang, P. H.; Liu, W.; Qiu, X. G. et al. Nanozyme-strip for rapid local diagnosis of Ebola. Biosens. Bioelectron. 2015, 74, 134–141.
Crossref Google Scholar
[18]

Liu, D.; Ju, C. H.; Han, C.; Shi, R.; Chen, X. H.; Duan, D. M.; Yan, J. H.; Yan, X. Y. Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen. Biosens. Bioelectron. 2021, 173, 112817.
Crossref Google Scholar
[19]

Jiang, B.; Duan, D. M.; Gao, L. Z.; Zhou, M. J.; Fan, K. L.; Tang, Y.; Xi, J. Q.; Bi, Y. H.; Tong, Z.; Gao, G. F. et al. Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes. Nat. Protoc. 2018, 13, 1506–1520.
Crossref Google Scholar
[20]

Gong, W.; Zhang, W. Q.; Son, F. A.; Yang, K. W.; Chen, Z. J.; Chen, X. F.; Jiang, J. W.; Liu, Y.; Farha, O. K.; Cui, Y. Topological strain-induced regioselective linker elimination in a chiral Zr(IV)-based metal-organic framework. Chem 2021, 7, 190–201.
Crossref Google Scholar
[21]

Dai, S.; Nouar, F.; Zhang, S. J.; Tissot, A.; Serre, C. One-step room-temperature synthesis of metal(IV) carboxylate metal-organic frameworks. Angew. Chem. 2021, 133, 4328–4334.
Crossref Google Scholar
[22]

Wei, D. L.; Zhang, X. Y.; Chen, B.; Zeng, K. Using bimetallic Au@Pt nanozymes as a visual tag and as an enzyme mimic in enhanced sensitive lateral-flow immunoassays: Application for the detection of streptomycin. Anal. Chim. Acta 2020, 1126, 106–113.
Crossref Google Scholar
[23]

Xu, B. L.; Wang, H.; Wang, W. W.; Gao, L. Z.; Li, S. S.; Pan, X. T.; Wang, H. Y.; Yang, H. L.; Meng, X. Q.; Wu, Q. W. et al. A single-atom nanozyme for wound disinfection applications. Angew. Chem., Int. Ed. 2019, 58, 4911–4916.
Crossref Google Scholar
[24]

Huang, L.; Chen, J. X.; Gan, L. F.; Wang, J.; Dong, S. J. Single-atom nanozymes. Sci. Adv. 2019, 5, eaav5490.
Crossref Google Scholar
[25]

Jiao, L.; Xu, W. Q.; Yan, H. Y.; Wu, Y.; Liu, C. R.; Du, D.; Lin, Y. H.; Zhu, C. Z. Fe-N-C single-atom nanozymes for the intracellular hydrogen peroxide detection. Anal. Chem. 2019, 91, 11994–11999.
Crossref Google Scholar
[26]

Leung, S. F.; Tam, J. S.; Chan, A. T. C.; Zee, B.; Chan, L. Y. S.; Huang, D. P.; Van Hasselt, A.; Johnson, P. J.; Lo, Y. M. D. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody. Clin. Chem. 2004, 50, 339–345.
Crossref Google Scholar
[27]

Connolly, Y.; Littler, E.; Sun, N.; Chen, X. Y.; Huang, P. C.; Stacey, S. N.; Arrand, J. R. Antibodies to Epstein-Barr virus thymidine kinase: A characteristic marker for the serological detection of nasopharyngeal carcinoma. 3.0.CO;2-G">Int. J. Cancer 2001, 91, 692–697.
Crossref Google Scholar
[28]

Ebrahim, A.; DeVore, K.; Fischer, T. Limitations of accelerated stability model based on the Arrhenius equation for shelf life estimation of in vitro diagnostic products. Clin. Chem. 2021, 67, 684–688.
Crossref Google Scholar
Nano Research
Volume 17 Issue 3,
March 2024
Pages 1827-1836
DOI: 10.1007/s12274-023-5915-4
Cite this article:
Wang D, Wang J, Liu D, et al. Rapid and sensitive detection of Epstein-Barr virus antibodies in nasopharyngeal carcinoma by chemiluminescence strips based on iron-porphyrin single atom nanozyme. Nano Research, 2024, 17(3): 1827-1836. https://doi.org/10.1007/s12274-023-5915-4
Topics:
Nano detectionNanocatalysts

746

Views

3

Crossref

5

Web of Science

4

Scopus

0

CSCD

Altmetrics
Received: 18 April 2023
Revised: 30 May 2023
Accepted: 11 June 2023
Published: 26 July 2023
© Tsinghua University Press 2023
Return